Jefferies Financial Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Jefferies Financial Group’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,000	Closed	-$1.53M	–	2096
2023 Q2	$1.53M	Buy	+15,000	New	+$1.42M	0.01%	758

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jefferies Financial Group's RETA Position: Q3 2023 in Review

Jefferies Financial Group sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 4,849 shares — an estimated $494K sold.

Jefferies Financial Group first reported a position in RETA in Q2 2023 and held it in 1 quarter. The position peaked at $494K in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Jefferies Financial Group reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Jefferies Financial Group sold 4,849 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $494K.
Jefferies Financial Group first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2023 and held it in 1 quarter.
Jefferies Financial Group's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $494K in Q2 2023.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Jefferies Financial Group's 13F filing for Q3 2023, filed 14 Nov 2023.